Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raynier Devillier

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
Bone Marrow Transplantation|September 15, 2025
Thiotepa-busulfan-fludarabine compared to clofarabine-based conditioning for haploidentical transplant with posttransplant cyclophosphamide in patients with myeloid malignancies: a retrospective study from the SFGM-TCMaxime Jullien, Eolia Brissot, Etienne Daguindau, et al.
Bone Marrow Transplantation|September 3, 2022
Impact of second-degree related donor on the outcomes of T cell-replete haploidentical transplantation with post-transplant cyclophosphamideJacopo Mariotti, Anna Maria Raiola, Andrea Evangelista, et al.
American Journal of Hematology|May 6, 2025
Allogeneic Hematopoietic Stem Cell Transplantation for Elderly Acute Lymphoblastic Leukemia Patients: A Registry Study From the Société Francophone de Greffe de Moelle et Thérapie Cellulaire (SFGM-TC)Yves Chalandon, Raynier Devillier, Ariane Boumendil, et al.
Blood Advances|September 9, 2025
Allogeneic hematopoietic stem cell transplantation in patients with germ line DDX41 mutated myeloid malignanciesMichael Loschi, Marie-Charlotte Villy, Jacques-Emmanuel Galimard, et al.
Haematologica|April 2, 2026
Hypomethylating agents plus venetoclax <i>versus</i> intensive chemotherapy prior to transplant in high-risk acute myeloid leukemiaGuillaume Berton, Jan Philipp Bewersdorf, Julia Gilhodes, et al.
Journal of Hematology & Oncology|January 7, 2024
Bone marrow graft versus peripheral blood graft in haploidentical hematopoietic stem cells transplantation: a retrospective analysis in1344 patients of SFGM-TC registryClaire Lacan, Jérôme Lambert, Edouard Forcade, et al.
NEJM Evidence|June 24, 2025
Intermediate-Dose Cytarabine as Postinduction AML TherapyMathilde Hunault, Cécile Pautas, Sarah Bertoli, et al.
Nature Medicine|March 27, 2019
Immune signature drives leukemia escape and relapse after hematopoietic cell transplantationCristina Toffalori, Laura Zito, Valentina Gambacorta, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Bone Marrow Transplantation|September 15, 2025
Thiotepa-busulfan-fludarabine compared to clofarabine-based conditioning for haploidentical transplant with posttransplant cyclophosphamide in patients with myeloid malignancies: a retrospective study from the SFGM-TCMaxime Jullien, Eolia Brissot, Etienne Daguindau, et al.
Bone Marrow Transplantation|September 3, 2022
Impact of second-degree related donor on the outcomes of T cell-replete haploidentical transplantation with post-transplant cyclophosphamideJacopo Mariotti, Anna Maria Raiola, Andrea Evangelista, et al.
American Journal of Hematology|May 6, 2025
Allogeneic Hematopoietic Stem Cell Transplantation for Elderly Acute Lymphoblastic Leukemia Patients: A Registry Study From the Société Francophone de Greffe de Moelle et Thérapie Cellulaire (SFGM-TC)Yves Chalandon, Raynier Devillier, Ariane Boumendil, et al.
Blood Advances|September 9, 2025
Allogeneic hematopoietic stem cell transplantation in patients with germ line DDX41 mutated myeloid malignanciesMichael Loschi, Marie-Charlotte Villy, Jacques-Emmanuel Galimard, et al.
Haematologica|April 2, 2026
Hypomethylating agents plus venetoclax <i>versus</i> intensive chemotherapy prior to transplant in high-risk acute myeloid leukemiaGuillaume Berton, Jan Philipp Bewersdorf, Julia Gilhodes, et al.
Journal of Hematology & Oncology|January 7, 2024
Bone marrow graft versus peripheral blood graft in haploidentical hematopoietic stem cells transplantation: a retrospective analysis in1344 patients of SFGM-TC registryClaire Lacan, Jérôme Lambert, Edouard Forcade, et al.
NEJM Evidence|June 24, 2025
Intermediate-Dose Cytarabine as Postinduction AML TherapyMathilde Hunault, Cécile Pautas, Sarah Bertoli, et al.
Nature Medicine|March 27, 2019
Immune signature drives leukemia escape and relapse after hematopoietic cell transplantationCristina Toffalori, Laura Zito, Valentina Gambacorta, et al.
Pageof 9